Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
It is engages in the research, development, production, marketing, and distribution of pharmaceutical products.
Zydus Lifesciences Limited, is a listed public company incorporated on 15 May, 1995. It is classified as a public limited company and is located in , . It's authorized share capital is INR 172.50 cr and the total paid-up capital is INR 100.62 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Sharvil Pankajbhai Patel
Shareholder
|
00131995 | 28 years |
Director | Bhadresh Kantilal Shah | 00058177 | 7 years |
Director | Monappa Arun Akhil | 09784366 | 3 years |
Director | Upasana Konidela | 02781278 | 3 years |
Director | Mukesh Mangalbhai Patel
Shareholder
|
00053892 | 28 years |
Whole-time Director | Ganesh Narayan Nayak
Shareholder
|
00017481 | 8 years |
Director | Pankaj Ramanbhai Patel
Shareholder
|
00131852 | 30 years |
Director | Apurva Shishir Diwanji | 00032072 | 9 years |
Director | Shelina Pranav Parikh | 00468199 | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ICICI Bank Limited
No. of Loans: 1
Total Amount : 1,500.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Zynext Ventures USA LLC | United States | - | - |
Zynext Ventures PTE. LTD | Singapore | - | - |
Zydus Pharmaceuticals UK Limited | United Kingdom | - | - |
DIALFORHEALTH UNITY LIMITED | Gujarat | 2005 | ₹ 5.0 L |
DIALFORHEALTH GREENCROSS LIMITED | Gujarat | 2005 | ₹ 25.0 L |
ZYDUS LANKA (PRIVATE) LIMITED | Sri Lanka | - | - |
ZYDUS HEALTHCARE PHILIPPINES INC. | Philippines | - | - |
ZYDUS INTERNATIONAL PRIVATE LIMITED | Ireland | - | - |
ZYDUS NETHERLANDS B.V. | Netherlands | - | - |
ZYDUS FRANCE, SAS | France | - | - |
LABORATORIOS COMBIX S.L. | Spain | - | - |
ETNA BIOTECH S.R.L. | Italy | - | - |
ZYDUS PHARMACEUTICALS (USA) INC. | United States | - | - |
ZYDUS HEALTHCARE (USA) LLC | United States | - | - |
LM MANUFACTURING INDIA PRIVATE LIMITED | Gujarat | 2017 | ₹ 5.0 L |
ZYDUS WORLDWIDE DMCC | United Arab Emirates | - | - |
ZYDUS HEALTHCARE S.A. (PTY) LTD | South Africa | - | - |
Alidac Pharmaceuticals SA Pty Ltd | South Africa | - | - |
SCRIPT MANAGEMENT SERVICES (PTY) LTD | South Africa | - | - |
ZYDUS NIKKHO FARMACEUTICA LTDA. | Brazil | - | - |
Alidac Healthcare (Myanmar) Limited | Myanmar | - | - |
Zydus Pharmaceuticals Mexico SA De CV | Mexico | - | - |
ZYDUS PHARMACEUTICALS MEXICO SERVICES COMPANY SA DE C.V. | Mexico | - | - |
Sentynl Therapeutics Inc. | United States | - | - |
GERMAN REMEDIES PHARMACEUTICALS PRIVATE LIMITED | Gujarat | 2010 | ₹ 66.8 Cr |
VIOLIO HEALTHCARE LIMITED | Gujarat | 2018 | ₹ 5.0 L |
ZYDUS WELLNESS PRODUCTS LIMITED | Gujarat | 2019 | ₹ 218.8 Cr |
LIVA INVESTMENT LIMITED | Gujarat | 2018 | ₹ 25.0 L |
LIVA NUTRITIONS LIMITED | Gujarat | 2018 | ₹ 3.0 Cr |
ZYDUS ANIMAL HEALTH AND INVESTMENTS LIMITED | Gujarat | 2018 | ₹ 1,774.4 Cr |
Viona Pharmaceuticals (USA) Inc. | United States | - | - |
ZYDUS PHARMACEUTICALS LIMITED | Gujarat | 2019 | ₹ 740.0 Cr |
BIOCHEM PHARMACEUTICAL PRIVATE LIMITED | Gujarat | 2017 | ₹ 1.0 L |
Zydus Wellness International DMCC | United Arab Emirates | - | - |
ZYDUS VTEC LIMITED | Gujarat | 2020 | ₹ 302.5 Cr |
ZYDUS STRATEGIC INVESTMENTS LIMITED | Gujarat | 2020 | ₹ 1.0 Cr |
Zydus Therapeutics Inc. (USA) | United States | - | - |
Zydus Wellness BD Pvt Ltd (Bangladesh) | Bangladesh | - | - |
ZYDUS HEALTHCARE LIMITED | Gujarat | 1989 | ₹ 21.6 Cr |
ZYDUS WELLNESS LIMITED | 1994 | ₹ 63.6 Cr | |
LM Manufacturing Limited | United Kingdom | - | - |
Medsolutions (Europe) Limited | United Kingdom | - | - |
LiqMeds Worldwide Limited | United Kingdom | - | - |
LiqMeds Limited | United Kingdom | - | - |
LiqMeds Lifecare Limited | United Kingdom | - | - |
Zydus Pharmaceuticals (Canda) Inc | Canada | - | - |
Zydus Lifesciences Global FZE | United Arab Emirates | - | - |
Nesher Pharmaceuticals (USA) LLC | United States | - | - |
ZyVet Animal Health Inc. | United States | - | - |
Zydus Noveltech Inc. | United States | - | - |
Hercon Pharmaceuticals, LLC | United States | - | - |
Read more
The incorporation date of ZYDUS LIFESCIENCES LIMITED is 15 May, 1995
The authorized share capital of ZYDUS LIFESCIENCES LIMITED is INR ₹ 172.5 Cr.
The paid-up capital of ZYDUS LIFESCIENCES LIMITED is INR ₹ 100.6 Cr.
The registered address of ZYDUS LIFESCIENCES LIMITED is Zydus Corporate Park,Scheme No. 63, Survey No. 536 Khoraj(Gandhinagar),Nr. Vaishnodevi Circ, le, Ahmedabad, Ahmedabad, Gujarat, India, 382481 - 382481
The CIN number of ZYDUS LIFESCIENCES LIMITED is L24230GJ1995PLC025878.